Filing Details

Accession Number:
0001181431-12-054153
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-10-09 16:01:43
Reporting Period:
2012-10-05
Filing Date:
2012-10-09
Accepted Time:
2012-10-09 16:01:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278710 Robert Coffman C/O Dynavax Technologies
2929 Seventh Street, Suite 100
Berkeley CA 94710
Chief Scientific Officer & Vp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Stock Option Acquisiton 2012-10-05 2,251 $1.50 43,576 No 4 M Direct
Common Stock Disposition 2012-10-05 695 $4.86 42,881 No 4 F Direct
Common Stock Disposition 2012-10-05 1,556 $4.86 41,325 No 4 S Direct
Common Stock Disposition 2012-10-05 3,111 $4.96 0 No 4 S Indirect See footnote.
Common Stock Disposition 2012-10-05 3,333 $4.96 37,992 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Indirect See footnote.
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2012-10-05 2,251 $0.00 2,251 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-01-22 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
  2. Not applicable.
  3. Represents shares held by Robert Coffman and Susan Coffman.
  4. Shares being exercised pursuant to options vested.